Search Results - Ronjon Chakraverty

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Do educated natural killer cells make the grade in treating acute myeloid leukemia? by Ronjon Chakraverty

    Published in Haematologica (2012-11-01)
    Get full text
    Article


  2. 2

    The road to refractory graft-versus-host disease is paved with good intentions by Daniel North, Ronjon Chakraverty

    Published in The Journal of Clinical Investigation (2024-04-01)
    Get full text
    Article


  3. 3

    Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease by Pedro Santos e Sousa, Pedro Santos e Sousa, Clare L. Bennett, Clare L. Bennett, Ronjon Chakraverty, Ronjon Chakraverty

    Published in Frontiers in Immunology (2018-05-01)
    Get full text
    Article


  4. 4

    The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype by Antonia O. Cuff, Francesca Sillito, Simone Dertschnig, Andrew Hall, Tu Vinh Luong, Ronjon Chakraverty, Victoria Male

    Published in Frontiers in Immunology (2019-09-01)
    Get full text
    Article


  5. 5

    Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy by Angelika Holler, Mathias Zech, Sara Ghorashian, Rebecca Pike, Alastair Hotblack, Pedro Veliça, Shao-An Xue, Ronjon Chakraverty, Emma C. Morris, Hans J. Stauss

    Published in Haematologica (2016-04-01)
    Get full text
    Article


  6. 6

    ALL-RIC trial protocol: a comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with... by David I Marks, Matthew Beasley, Ronjon Chakraverty, Anna Castleton, Eduardo Olavarria, Maria Gilleece, Adele Fielding, George Mikhaeel, Patricia Diez, Aimee Jackson, Andrea Hodgkinson, Mohamed Elhanied

    Published in BMJ Open (2023-06-01)
    Get full text
    Article


  7. 7

    Multicentre adaptive randomised trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin versus calcineurin inhibitor-based or sirolimu... by Simon Gates, Matthew Collin, Victoria Potter, Rebecca Bishop, Ronjon Chakraverty, Kavita Raj, Adrian Bloor, Andrea Hodgkinson, Jeff Davies, Emma Kempshall, Fiona Dignan, Ram Malladi, Siobhan Smith, Charlotte Gaskell, Gabrielle Smith

    Published in BMJ Open (2025-01-01)
    Get full text
    Article


  8. 8

    Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function by Maria M. Cuadrado, Richard M. Szydlo, Mike Watts, Nishil Patel, Hanna Renshaw, Jude Dorman, Mark Lowdell, Stuart Ings, Chloe Anthias, Alejandro Madrigal, Stephen Mackinnon, Panagiotis Kottaridis, Ben Carpenter, Rachael Hough, Emma Morris, Kirsty Thomson, Karl S. Peggs, Ronjon Chakraverty

    Published in Haematologica (2019-11-01)
    Get full text
    Article


  9. 9

    Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus studyResearch in context by Sarah E. Hughes, Foram Khatsuria, Christel McMullan, Karen L. Shaw, Anita Walker, Francesca Kinsella, David Burns, Olalekan L. Aiyegbusi, Elin Haf Davies, John Ansell, Evelyn Chakera, Charles Craddock, Alastair Denniston, Rebecca Lloyd, Paul Ferguson, Ronjon Chakraverty, Melanie Calvert

    Published in EClinicalMedicine (2025-06-01)
    Get full text
    Article


Search Tools: